Brian Michael Andresen

Title: Brian Michael Andresen: Innovator in Pharmaceutical Compounds

Introduction

Brian Michael Andresen is an inventor based in Sharon, MA (US). He is known for his work in developing pharmaceutical compounds, particularly those that target Spleen Tyrosine Kinase (Syk) inhibitors. Although he currently holds no granted patents, his contributions to the field of medicinal chemistry are noteworthy.

Latest Patent Applications

Brian Michael Andresen has submitted several patent applications, including the following:

1. **Amino-Pyridine-Containing Spleen Tyrosine Kinase (Syk) Inhibitors** - This invention provides certain amino-pyridine-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R, R, R, R, and the subscript n are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

2. **Amino-Pyridine-Containing Spleen Tyrosine Kinase (Syk) Inhibitors** - This application is similar to the previous one, providing certain amino-pyridine-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, with specific definitions for R, R, R, R, R, R, R, R, R, and n. It also includes pharmaceutical compositions and methods for treating conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

Conclusion

Brian Michael Andresen is an emerging inventor in the field of pharmaceutical innovations, focusing on compounds that inhibit Spleen Tyrosine Kinase. His latest patent applications reflect his commitment to advancing medical treatments.